ImmunoCAP
Device
Phadia US Inc.
Total Payments
$3.0M
Transactions
37,281
Doctors
24,019
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $319,629 | 6,876 | 5,796 |
| 2023 | $356,771 | 6,053 | 5,184 |
| 2022 | $305,848 | 4,651 | 3,972 |
| 2021 | $214,725 | 4,618 | 3,867 |
| 2020 | $223,707 | 1,477 | 1,291 |
| 2019 | $446,233 | 3,446 | 2,925 |
| 2018 | $447,324 | 6,086 | 4,861 |
| 2017 | $659,630 | 4,074 | 3,375 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $794,734 | 36,436 | 26.7% |
| Unspecified | $752,120 | 77 | 25.3% |
| Honoraria | $745,839 | 422 | 25.1% |
| Consulting Fee | $546,777 | 145 | 18.4% |
| Travel and Lodging | $128,640 | 197 | 4.3% |
| Education | $2,531 | 1 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,225 | 2 | 0.1% |
| Charitable Contribution | $1,000 | 1 | 0.0% |
Payments by Type
General
$2.2M
37,204 transactions
Research
$752,120
77 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Investigation of IgG4 and IgE Antibodies to the component proteins of Milk, Other Foods and inhalants associated with EoE | Phadia US Inc. | $125,880 | 0 |
| Development of IgG4 and IgE antibodies to food and food antigens during first 3 years of life in a random cohort | Phadia US Inc. | $122,376 | 0 |
| Diagnostic Performance of Boiled Milk IGE CAP in baked milk allergy in children | Phadia US Inc. | $97,218 | 0 |
| Investigating the Relevance of IgE to galactose (a-Gal) in coronary artery disease - CABAL 2015 CF | Phadia US Inc. | $61,459 | 0 |
| Improving Asthma Outcomes | Phadia US Inc. | $46,381 | 0 |
| Dietary Management of Adult and Childrens Eosinphilic Esophagitis: The Efficacy of dietary interventions | Phadia US Inc. | $45,641 | 0 |
| IDEA Investigating Duliumabs Effect on Asthma by Genotype- CABAL 1922 | Phadia US Inc. | $42,540 | 0 |
| Dietary Management of Adult Eosinphilic Esophagitis: The Efficacy of dietary interventions | Phadia US Inc. | $39,287 | 0 |
| Controlling and Preventing Asthma Progression and Severity in kids with Omalizumab-Preventing Asthmas in High Risk Kids (PARK | Phadia US Inc. | $31,417 | 0 |
| Allergen Sensitization and Exposure Pilot | Phadia US Inc. | $30,640 | 0 |
| Duke Prestige Award Aeroallergen-sensitization and pulmunary function outcomes in children ith chronic respiratory disease | Phadia US Inc. | $25,000 | 0 |
| Inner City Asthma | Phadia US Inc. | $18,433 | 0 |
| Relevance of Der p23 to symptoms of asthma and rhinitis in an unselected birth cohort | Phadia US Inc. | $17,919 | 0 |
| Tryptase | Phadia US Inc. | $16,225 | 0 |
| Improving Technology-Assisted Recording of Asthma Control in Children | Phadia US Inc. | $11,693 | 0 |
| CABAL 1803 Allergen Specific Component Resolved Diagnostics and Atopic Progression Profiling in Context of Omalizumab Asthma Preventention Trial | Phadia US Inc. | $7,680 | 0 |
| Testing the Efficacy of school based environmental intervention targeting pest allergens, mold and pollution | Phadia US Inc. | $4,874 | 0 |
| PARK CABAL 1803 Allergen Specific Component Resolved Diagnostics and Atopic Progression Profiling in Context of Omalizumab Asthma Preventention Trial | Phadia US Inc. | $4,510 | 0 |
| CABAL 1718 The Microbiome, Asthma and Other Atopic Development in the Premature Population | Phadia US Inc. | $2,100 | 0 |
| Multi Allergic Pilot Study | Phadia US Inc. | $592.00 | 0 |
Top Doctors Receiving Payments for ImmunoCAP — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD, MBA | Pediatrics | Englewood, CO | $8,284 | 8 |
| , MD | Pediatrics | Potomac, MD | $7,919 | 8 |
| , M.D | Allergy | Baltimore, MD | $6,903 | 5 |
| , M.D | Family Medicine | Little Rock, AR | $6,045 | 8 |
| , APRN, FNP-C | Family | Kenner, LA | $5,897 | 6 |
| , M.D | Pediatrics | New York, NY | $5,544 | 4 |
| Daniel Garcia | Pediatrics | Orlando, FL | $5,440 | 9 |
| , D.O | Internal Medicine | Redlands, CA | $5,389 | 32 |
| , MD | Allergy & Immunology | Austin, TX | $5,328 | 12 |
| , MD | Rheumatology | Winnetka, IL | $5,000 | 2 |
| , M.D | Pediatric Allergy/Immunology | New York, NY | $4,866 | 6 |
| , M.D., | Pediatric Allergy/Immunology | Miami Lakes, FL | $4,026 | 8 |
| , MD | Pediatrics | Columbia, SC | $3,939 | 10 |
| , M.D | Allergy & Immunology | Saint Louis, MO | $3,903 | 14 |
| , MD | Endocrinology, Diabetes & Metabolism | St. Louis, MO | $3,708 | 3 |
| , MD | Pediatric Pulmonology | Tampa, FL | $3,307 | 18 |
| , M.D, | Pediatric Gastroenterology | Chicago, IL | $2,675 | 2 |
| , MD | Rheumatology | Chapel Hill, NC | $2,544 | 2 |
| , M.D | Internal Medicine | Shaker Heights, OH | $2,500 | 2 |
| , M.D | Family Medicine | Puyallup, WA | $2,413 | 24 |
| , PA-C, MMS | Allergy | Hayward, CA | $2,216 | 5 |
| , MD | Allergy | Sherman Oaks, CA | $2,186 | 3 |
| , M.D | Allergy & Immunology | Houston, TX | $2,169 | 4 |
| , M.D | Internal Medicine | Richmond, VA | $2,000 | 3 |
| , M.D | Internal Medicine | Norfolk, VA | $2,000 | 1 |
Ad
Manufacturing Companies
- Phadia US Inc. $3.0M
Product Information
- Type Device
- Total Payments $3.0M
- Total Doctors 24,019
- Transactions 37,281
About ImmunoCAP
ImmunoCAP is a device associated with $3.0M in payments to 24,019 healthcare providers, recorded across 37,281 transactions in the CMS Open Payments database. The primary manufacturer is Phadia US Inc..
Payment data is available from 2017 to 2024. In 2024, $319,629 was paid across 6,876 transactions to 5,796 doctors.
The most common payment nature for ImmunoCAP is "Food and Beverage" ($794,734, 26.7% of total).
ImmunoCAP is associated with 20 research studies, including "Investigation of IgG4 and IgE Antibodies to the component proteins of Milk, Other Foods and inhalants associated with EoE" ($125,880).